Eloxx Pharmaceuticals Stock Price. Everything You Need To Know About The Eloxx Pharmaceuticals Stock!
Eloxx Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Watertown, Massachusetts, with 18 full-time employees. The company went IPO on November 23, 2012.
Eloxx Pharmaceuticals focuses on developing novel ribonucleic acid-modulating drug candidates, with a specific focus on ribosome modulation. By leveraging its TURBO-ZM chemistry technology platform and library of aminoglycosides, the company is developing oral small molecule ribosome modulating agents (RMAs) and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare premature stop codon diseases and ribosomal mutations.
The company’s lead product candidate, ELX-02, is an investigational ERSG designed to restore production of full-length functional proteins. ELX-02 is based on aminoglycoside antibiotics such as gentamicin, but with increased selectivity for the eukaryotic ribosome.
Eloxx Pharmaceuticals’ preclinical programs are focused on select rare diseases, including inherited diseases, cancer caused by nonsense mutations, kidney diseases, including autosomal dominant polycystic kidney disease, as well as rare ocular genetic disorders.
Investors interested in the pharmaceutical industry may want to consider researching Eloxx Pharmaceuticals, Inc. Keeping track of the company’s stock price, shares, and premarket trading activity can provide valuable insights into potential buying or selling opportunities. However, it’s important to do thorough research and consult with a financial advisor before making any investment decisions.
Eloxx Pharmaceuticals Stock Price. Everything You Need To Know About The Eloxx Pharmaceuticals Stock! performance
- Employees 18
- Company HQ Watertown
- Website https://www.eloxxpharma.com/
- ELOX Asset Type Common Stock
- ELOX Market Capitalization 2.5M
- Earnings Per Share -8.88
- Dividends Per Share None
- Dividend Date 2017-12-20
- Quarterly Earnings Growth 0
Are you looking to invest in the pharmaceutical industry? Look no further than Eloxx Pharmaceuticals. With a mission to develop innovative medicines for patients with rare and ultra-rare genetic diseases, Eloxx has become a leader in the biopharmaceutical sector. But how can you invest in Eloxx Pharmaceuticals from Malaysia, Thailand, Indonesia, or Vietnam? Zorion, the ultimate investment platform, has got you covered. With its user-friendly interface, Zorion allows retail investors like you to access real US stocks and Pre-IPO companies, including Eloxx Pharmaceuticals. To make informed investment decisions, Zorion provides you with valuable investment insights and recommendations. Additionally, you can expand your investment knowledge by accessing resources and educational materials tailored to your needs. Don’t miss out on the opportunity to invest in promising stocks like Eloxx Pharmaceuticals. Join Zorion today and unlock your investing potential.
